Dr. Aqeel A. Gillani
Claim this profileGlens Falls Hospital
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
33 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Aqeel A. Gillani is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting1 award N/A9 criteria
More about Aqeel A. Gillani
Clinical Trial Related5 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Aqeel A. Gillani has experience with
- Carboplatin
- Pembrolizumab
- Nivolumab
- Pemetrexed
- Cisplatin
- Durvalumab
Breakdown of trials Aqeel A. Gillani has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aqeel A. Gillani specialize in?
Aqeel A. Gillani focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Aqeel A. Gillani currently recruiting for clinical trials?
Yes, Aqeel A. Gillani is currently recruiting for 7 clinical trials in Glens Falls New York. If you're interested in participating, you should apply.
Are there any treatments that Aqeel A. Gillani has studied deeply?
Yes, Aqeel A. Gillani has studied treatments such as Carboplatin, Pembrolizumab, Nivolumab.
What is the best way to schedule an appointment with Aqeel A. Gillani?
Apply for one of the trials that Aqeel A. Gillani is conducting.
What is the office address of Aqeel A. Gillani?
The office of Aqeel A. Gillani is located at: Glens Falls Hospital, Glens Falls, New York 12801 United States. This is the address for their practice at the Glens Falls Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.